Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
The FDA said Summit Therapeutics’ lung cancer drug ivonescimab, developed in China, failed to show a statistically significant survival benefit.
The post FDA Doesn’t Approve Summit’s China-Developed Lung Cancer Drug appeared first on Investor’s Business Daily.